Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

71 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Multimarker scores of Th1 and Th2 immune cellular profiles in peripheral blood predict response and immune related toxicity with CTLA4 blockade and IFNα in melanoma.
Khunger A, Sarikonda G, Tsau J, Pahuja A, Alfonso Z, Gao J, Laing C, Vaupel C, Dakappagari N, Tarhini AA. Khunger A, et al. Among authors: pahuja a. Transl Oncol. 2021 Mar;14(3):101014. doi: 10.1016/j.tranon.2021.101014. Epub 2021 Jan 12. Transl Oncol. 2021. PMID: 33450703 Free PMC article.
Best practices for the development, analytical validation and clinical implementation of flow cytometric methods for chimeric antigen receptor T cell analyses.
Sarikonda G, Mathieu M, Natalia M, Pahuja A, Xue Q, Pierog PL, Trampont PC, Decman V, Reynolds S, Hanafi LA, Sun YS, Eck S, Hedrick MN, Stewart JJ, Tangri S, Litwin V, Dakappagari N. Sarikonda G, et al. Among authors: pahuja a. Cytometry B Clin Cytom. 2021 Jan;100(1):79-91. doi: 10.1002/cyto.b.21985. Epub 2020 Dec 29. Cytometry B Clin Cytom. 2021. PMID: 33373096 Free article. Review.
Neoadjuvant Pembrolizumab and High-Dose IFNα-2b in Resectable Regionally Advanced Melanoma.
Najjar YG, McCurry D, Lin H, Lin Y, Zang Y, Davar D, Karunamurthy A, Drabick JJ, Neves RI, Butterfield LH, Ernstoff MS, Puzanov I, Skitzki JJ, Bordeaux J, Summit IB, Bender JO, Kim JY, Chen B, Sarikonda G, Pahuja A, Tsau J, Alfonso Z, Laing C, Pingpank JF, Holtzman MP, Sander C, Rose A, Zarour HM, Kirkwood JM, Tarhini AA. Najjar YG, et al. Among authors: pahuja a. Clin Cancer Res. 2021 Aug 1;27(15):4195-4204. doi: 10.1158/1078-0432.CCR-20-4301. Epub 2021 Mar 22. Clin Cancer Res. 2021. PMID: 33753453 Free PMC article.
Analytical assay validation for acute myeloid leukemia measurable residual disease assessment by multiparametric flow cytometry.
Tettero JM, Dakappagari N, Heidinga ME, Oussoren-Brockhoff Y, Hanekamp D, Pahuja A, Burns K, Kaur P, Alfonso Z, van der Velden VHJ, Te Marvelde JG, Hobo W, Slomp J, Bachas C, Kelder A, Nguyen K, Cloos J. Tettero JM, et al. Among authors: pahuja a. Cytometry B Clin Cytom. 2023 Nov;104(6):426-439. doi: 10.1002/cyto.b.22144. Epub 2023 Sep 28. Cytometry B Clin Cytom. 2023. PMID: 37766649
Tri-modality therapy in advanced esophageal carcinoma: long-term results and insights from a developing world, institutional cohort.
Chufal KS, Ahmad I, Bajpai R, Miller AA, Chowdhary RL, Makker J, Batra U, Nathany S, Sharief MI, Umesh P, Sharma M, Amrith P, Pahuja AK, Sethi J, Antony V, Gairola M. Chufal KS, et al. Among authors: pahuja ak. Br J Radiol. 2023 Mar;96(1143):20220413. doi: 10.1259/bjr.20220413. Epub 2023 Jan 12. Br J Radiol. 2023. PMID: 36541255 Free PMC article.
Dosimetric analysis of intensity-modulated radiation therapy and volumetric-modulated arc therapy in comparison with conventional box technique in the treatment of carcinoma cervix: An impact of prosthetic implant.
Bhushan M, Tripathi D, Yadav G, Kumar L, Chowdhary RL, Pahuja AK, Suhail M, Mitra S, Gairola M. Bhushan M, et al. Among authors: pahuja ak. J Cancer Res Ther. 2022 Oct-Dec;18(6):1504-1512. doi: 10.4103/jcrt.JCRT_835_20. J Cancer Res Ther. 2022. PMID: 36412401 Free article.
71 results